192 related articles for article (PubMed ID: 3175366)
1. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
[No Abstract] [Full Text] [Related]
2. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
Wang Z; Xu W; Liu L; Ding Z
Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632
[No Abstract] [Full Text] [Related]
3. Transverse myelopathy following intrathecal administration of chemotherapy.
Teh HS; Fadilah SA; Leong CF
Singapore Med J; 2007 Feb; 48(2):e46-9. PubMed ID: 17304378
[TBL] [Abstract][Full Text] [Related]
4. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
Chamberlain MC; Glantz MJ
Blood; 2007 Sep; 110(5):1698; author reply 1698-9. PubMed ID: 17712051
[No Abstract] [Full Text] [Related]
5. Progressive paresthesia and weakness after intrathecal chemotherapy.
Marshall R; Gupta ND; Palacios E; Neitzschman HR
J La State Med Soc; 2008; 160(2):92-4. PubMed ID: 18681351
[TBL] [Abstract][Full Text] [Related]
6. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
Yegin ZA; Aki S; Sucak G; Yagci M
Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
[No Abstract] [Full Text] [Related]
7. Pure motor lumbosacral radiculopathy after intrathecal chemotherapy.
Santos-García D; Pardo J; Vázquez F; Rabuñal-Martínez MJ; Martín-Vigo AI; de la Fuente-Fernández R
Eur J Neurol; 2008 Aug; 15(8):e86-7. PubMed ID: 18549396
[No Abstract] [Full Text] [Related]
8. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
Rausch CR; Jabbour EJ; Kantarjian HM; Kadia TM
Cancer; 2020 Mar; 126(6):1152-1160. PubMed ID: 31794095
[No Abstract] [Full Text] [Related]
10. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel P; Khangure M
Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
[No Abstract] [Full Text] [Related]
11. [Transverse leukonychia and anti-leukemia chemotherapy].
Bader-Meunier B; Garel D; Dommergues JP; Venencie PY
Ann Pediatr (Paris); 1990 May; 37(5):337-8. PubMed ID: 2369052
[TBL] [Abstract][Full Text] [Related]
12. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Kingma A; Van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
J Pediatr Hematol Oncol; 2002 Feb; 24(2):106-14. PubMed ID: 11990695
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
14. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
15. [Paraplegia following intrathecal chemotherapy].
Beretta F; Sanna P; Ghielmini M; Marini G; Cavalli F
Schweiz Med Wochenschr; 1996 Jun; 126(25):1107-11. PubMed ID: 8711459
[TBL] [Abstract][Full Text] [Related]
16. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
Jabbour E; O'Brien S; Kantarjian H; Garcia-Manero G; Ferrajoli A; Ravandi F; Cabanillas M; Thomas DA
Blood; 2007 Apr; 109(8):3214-8. PubMed ID: 17209054
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of neuroleukemia by intrathecal administration of cytosar and methotrexate in acute lymphoblastic leukemia in adults].
Filatov LB; Konstantinova TS; Shalaev VA
Ter Arkh; 1999; 71(10):38-40. PubMed ID: 10612172
[TBL] [Abstract][Full Text] [Related]
18. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
[TBL] [Abstract][Full Text] [Related]
19. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol].
de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M
Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
